National Cancer Institute
Cancer Imaging Program
Print Friendly Version | Text Only | Contact Us  
Home
About CIP
Research Funding
 
Current Funding Opportunities
 
Past Funding Opportunities
 
Mechanisms
 
Application Guidelines
 
Career Training and Education
Programs & Resources
Clinical Trials
Reports & Publications
News & Meetings
Imaging Information
Imaging Guidelines
Research Funding
PAR-03-124: Novel Technologies for In vivo Imaging (R21/R33)

PAR-03-124 has been replaced by PA-04-095, which uses Regular Receipt Dates: June 1, October 1, and February 1.

The National Cancer Institute (NCI) and the National Institute for Biomedical Imaging and Bioengineering (NIBIB) invite applications for the development and delivery of novel image acquisition or enhancement technology and methods for biomedical imaging and image-guided interventions and therapy, and which may incorporate limited pilot or clinical feasibility evaluations using either pre-clinical models or clinical studies. This initiative is intended to facilitate the proof of feasibility, development and delivery of novel imaging technologies for early detection, screening, diagnosis, image-guided interventions, and treatment of various diseases, and secondarily to facilitate limited evaluation studies to show proof of concept and functionality.

  • Release Date: May 19, 2003
  • Letter of Intent Receipt Date(s): June 23, 2003 and October 22, 2003
  • Application Receipt Date(s): July 21, 2003 and November 19, 2003
  • Contact: Houston Baker, Ph.D. (bakerhou@mail.nih.gov)

See full description in NIH Guide: PAR-03-124

See full description in NIH Guide: PA-04-095

National Cancer InstituteDepartment of Health & Human ServicesNational Institutes of HealthFirstGov.gov